Baxter S.A. (testing of composition components; testing of intermediate product (amino acid mixture); production of container/closure system; production of medicinal product, filling, overpouching; sterilization and packaging; testing of medicinal product; batch release)

Ukraine

All drugs from this manufacturer

  • NUMETA G13E

    The drug is used for parenteral (intravenous) nutrition of preterm infants in cases where they cannot receive sufficient nutrients orally or through the gastrointestinal tract.

    Dosage form: emulsion, for infusion

    Active substance Dosage
    amino acid electrolyte glucose lipid mixture 0

    ATC: B05BA10

  • The drug is used for parenteral (intravenous) nutrition of full-term newborns and children up to 2 years of age in cases where conventional oral or enteral feeding is impossible, insufficient, or contraindicated.

    Dosage form: emulsion, for infusion

    Active substance Dosage
    amino acids electrolytes glucose and oil mixture olive and soybean 0

    ATC: B05BA10

  • The drug is used for parenteral (intravenous) nutrition of children from 2 years of age and adolescents aged 16–18 years in cases where normal oral or enteral feeding is impossible, insufficient, or contraindicated.

    Dosage form: emulsion, for infusion

    Active substance Dosage
    mixture of amino acids electrolytes glucose and plant oils 0

    ATC: B05BA10